Literature DB >> 24196965

The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1 (MiR-21/PDCD4/AP-1) as a driving force for hepatic fibrosis development.

Zhengping Zhang1, Yinhe Zha, Wei Hu, Zhen Huang, Zhongfei Gao, Yuhui Zang, Jiangning Chen, Lei Dong, Junfeng Zhang.   

Abstract

Sustained activation of hepatic stellate cells (HSCs) leads to hepatic fibrosis, which is characterized by excessive collagen production, and for which there is no available drug clinically. Despite tremendous progress, the cellular activities underlying HSC activation, especially the driving force in the perpetuation stage, are only partially understood. Recently, microRNA-21 (miR-21) has been found to be prevalently up-regulated during fibrogenesis in different tissues, although its detailed role needs to be further elucidated. In the present study, miR-21 expression was examined in human cirrhotic liver samples and in murine fibrotic livers induced by thioacetamide or carbon tetrachloride. A dramatic miR-21 increase was noted in activated HSCs. We further found that miR-21 maintained itself at constant high levels by using a microRNA-21/programmed cell death protein 4/activation protein-1 (miR-21/PDCD4/AP-1) feedback loop. Disrupting this loop with miR-21 antagomir or AP-1 inhibitors significantly suppressed fibrogenic activities in HSCs and ameliorated liver fibrosis. In contrast, reinforcing this loop with small interfering RNA (siRNA) against PDCD4 promoted fibrogenesis in HSCs. Further analysis indicated that the up-regulated miR-21 promoted the central transforming growth factor-β (TGF-β) signaling pathway underlying HSC activation. In summary, we suggest that the miR-21/PDCD4/AP-1 autoregulatory loop is one of the main driving forces for hepatic fibrosis progression. Targeting this aberrantly activated feedback loop may provide a new therapeutic strategy and facilitate drug discovery against hepatic fibrosis.

Entities:  

Keywords:  Fibrosis; Hepatic Stellate Cells; Liver Injury; MicroRNA; Transforming Growth Factor β (TGFβ)

Mesh:

Substances:

Year:  2013        PMID: 24196965      PMCID: PMC3873564          DOI: 10.1074/jbc.M113.517953

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

Review 1.  Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.

Authors:  Y Chinenov; T K Kerppola
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 2.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans.

Authors:  Rebecca T Marquez; Sarmistha Bandyopadhyay; Erik B Wendlandt; Kathy Keck; Brandon A Hoffer; Michael S Icardi; Randolph N Christensen; Warren N Schmidt; Anton P McCaffrey
Journal:  Lab Invest       Date:  2010-07-12       Impact factor: 5.662

4.  SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells.

Authors:  Kristie R Ross; Deborah A Corey; John M Dunn; Thomas J Kelley
Journal:  Cell Signal       Date:  2006-11-25       Impact factor: 4.315

5.  Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts.

Authors:  S Dooley; B Delvoux; B Lahme; K Mangasser-Stephan; A M Gressner
Journal:  Hepatology       Date:  2000-05       Impact factor: 17.425

6.  Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells.

Authors:  Lisa B Frankel; Nanna R Christoffersen; Anders Jacobsen; Morten Lindow; Anders Krogh; Anders H Lund
Journal:  J Biol Chem       Date:  2007-11-08       Impact factor: 5.157

7.  miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism.

Authors:  Shuji Fujita; Taiji Ito; Taketoshi Mizutani; Shigeru Minoguchi; Nobutake Yamamichi; Kouhei Sakurai; Hideo Iba
Journal:  J Mol Biol       Date:  2008-03-15       Impact factor: 5.469

8.  Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs.

Authors:  Arthur C K Chung; Yuan Dong; Weiqin Yang; Xiang Zhong; Rong Li; Hui Y Lan
Journal:  Mol Ther       Date:  2012-12-04       Impact factor: 11.454

9.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis.

Authors:  Andrea Noetel; Monika Kwiecinski; Natalia Elfimova; Jia Huang; Margarete Odenthal
Journal:  Front Physiol       Date:  2012-03-19       Impact factor: 4.566

View more
  55 in total

1.  Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.

Authors:  Victoria N Parikh; Joseph Park; Ivana Nikolic; Richard Channick; Paul B Yu; Teresa De Marco; Priscilla Y Hsue; Stephen Y Chan
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

2.  Is miR-21 a potent target for liver fibrosis?

Authors:  Sanchuan Lai; Yasuko Iwakiri
Journal:  Hepatology       Date:  2018-04-19       Impact factor: 17.425

3.  Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia.

Authors:  Hui-Min Fan; Xin-Yang Sun; Wei Niu; Lin Zhao; Qiao-Li Zhang; Wan-Shuai Li; Ai-Fang Zhong; Li-Yi Zhang; Jim Lu
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

4.  Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells.

Authors:  Shadan Ali; Raagini Suresh; Sanjeev Banerjee; Bin Bao; Zhihong Xu; Jeremy Wilson; Philip A Philip; Minoti Apte; Fazlul H Sarkar
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

5.  MiR-21 is required for anti-tumor immune response in mice: an implication for its bi-directional roles.

Authors:  W He; C Wang; R Mu; P Liang; Z Huang; J Zhang; L Dong
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

Review 6.  Pathobiology of liver fibrosis: a translational success story.

Authors:  Youngmin A Lee; Michael C Wallace; Scott L Friedman
Journal:  Gut       Date:  2015-02-13       Impact factor: 23.059

Review 7.  Mechanisms of hepatic stellate cell activation.

Authors:  Takuma Tsuchida; Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-10       Impact factor: 46.802

8.  Transforming growth factor-β-sphingosine kinase 1/S1P signaling upregulates microRNA-21 to promote fibrosis in renal tubular epithelial cells.

Authors:  Xiujuan Liu; Quan Hong; Zhen Wang; Yanyan Yu; Xin Zou; Lihong Xu
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-16

9.  MYCN-driven regulatory mechanisms controlling LIN28B in neuroblastoma.

Authors:  Anneleen Beckers; Gert Van Peer; Daniel R Carter; Moritz Gartlgruber; Carl Herrmann; Saurabh Agarwal; Hetty H Helsmoortel; Kristina Althoff; Jan J Molenaar; Belamy B Cheung; Johannes H Schulte; Yves Benoit; Jason M Shohet; Frank Westermann; Glenn M Marshall; Jo Vandesompele; Katleen De Preter; Frank Speleman
Journal:  Cancer Lett       Date:  2015-06-26       Impact factor: 8.679

Review 10.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.